x

Posted 03 June, 2022

cbdMD, Inc. appointed new CEO

CEO Change detected for ticker NYSE:YCBD in a 8-K filed on 03 June, 2022.


  On June 3, 2022 (the "Effective Date") Scott G. Stephen, a member of the board of directors of cbdMD, Inc. (the "Company") assumed the position of chairman of the board of directors of the Company as Martin A. Sumichrast agreed to vacate the position of chairman of the board of directors on the Effective Date. Mr. Sumichrast shall remain on the Company's board of directors and continue to serve as the Company's chief executive officer.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of cbdMD, Inc.
Health Care/Life Sciences • Pharmaceuticals
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.
Market Cap
$2.12M
View Company Details
cbdMD, Inc. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


On June 3, 2022 (the "Effective Date") Scott G. Stephen, a member of the board of directors of cbdMD, Inc. (the "Company") assumed the position of chairman of the board of directors of the Company as Martin A. Sumichrast agreed to vacate the position of chairman of the board of directors on the Effective Date. Mr. Sumichrast shall remain on the Company's board of directors and continue to serve as the Company's chief executive officer.


2